Bluejay Diagnostics (BJDX) Non Operating Interest Expenses (2024 - 2025)
Bluejay Diagnostics' (BJDX) quarterly Non Operating Interest Expenses came in at $187.0 in Q4 2025, down 74.35% year-over-year from $729.0 in Q4 2024, and down 6.5% quarter-over-quarter from $200.0 in Q3 2025.
Powered by 
Analysis
Bluejay Diagnostics (BJDX) Non Operating Interest Expenses (2024 - 2025) Analysis & Trends
Bluejay Diagnostics has disclosed Non Operating Interest Expenses across 2 years of filings, most recently posting $187.0 for Q4 2025.
- In Q4 2025, Non Operating Interest Expenses fell 74.35% year-over-year to $187.0; the TTM figure through Dec 2025 stood at $1338.0 (changed N/A YoY), while the FY2025 annual figure was $839.0, down 99.9% from the prior year.
- Non Operating Interest Expenses came in at $187.0 for Q4 2025 at Bluejay Diagnostics, down from $200.0 in the prior quarter.
- In the past five years, Non Operating Interest Expenses ranged from a high of $626471.0 in Q2 2024 to a low of $187.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.85 Bn | 27.74 Bn | 2.18 Bn | 114.00 Mn |
| 2 | Lantheus Holdings | 6.57 Bn | 5.98 Bn | 241.86 Mn | 4.92 Mn |
| 3 | Heartflow | 4.11 Bn | 3.74 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.59 Bn | 2.40 Bn | 107.80 Mn | - |
| 5 | Butterfly Network | 1.99 Bn | 1.87 Bn | 23.29 Mn | 3.59 Mn |
| 6 | Ceribell | 924.56 Mn | 795.30 Mn | 25.94 Mn | 438,000.00 |
| 7 | QuidelOrtho | 874.92 Mn | 751.52 Mn | - | - |
| 8 | Varex Imaging | 779.06 Mn | 679.86 Mn | 76.70 Mn | 5.80 Mn |
| 9 | Prenetics Global | 340.90 Mn | 281.85 Mn | 30.20 Mn | - |
| 10 | Bluejay Diagnostics | 1.96 Mn | 1.96 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 187.00 |
| Sep 30, 2025 | 200.00 |
| Jun 30, 2025 | 222.00 |
| Dec 31, 2024 | 729.00 |
| Sep 30, 2024 | 190,610.00 |
| Jun 30, 2024 | 626,471.00 |